Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
- PMID: 19077110
- DOI: 10.1111/j.1365-2990.2008.01005.x
Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases
Abstract
The causes of most neurological disorders are not fully understood. Inflammation and blood-brain barrier dysfunction appear to play major roles in the pathology of these diseases. Inflammatory insults that occur during brain development may have widespread effects later in life for a spectrum of neurological disorders. In this review, a new hypothesis suggesting a mechanistic link between inflammation and blood-brain barrier function (integrity), which is universally important in both neurodevelopmental and neurodegenerative diseases, is proposed. The role of inflammation and the blood-brain barrier will be discussed in cerebral palsy, schizophrenia, Parkinson's disease, Alzheimer's disease and multiple sclerosis, conditions where both inflammation and blood-brain barrier dysfunction occur either during initiation and/or progression of the disease. We suggest that breakdown of normal blood-brain barrier function resulting in a short-lasting influx of blood-born molecules, in particular plasma proteins, may cause local damage, such as reduction of brain white matter observed in some newborn babies, but may also be the mechanism behind some neurodegenerative diseases related to underlying brain damage and long-term changes in barrier properties.
Similar articles
-
Effect of minocycline on inflammation-induced damage to the blood-brain barrier and white matter during development.Eur J Neurosci. 2007 Dec;26(12):3465-74. doi: 10.1111/j.1460-9568.2007.05973.x. Eur J Neurosci. 2007. PMID: 18088277
-
Factors involved in inflammation-induced developmental white matter damage.Neurosci Lett. 2009 Feb 27;451(3):232-6. doi: 10.1016/j.neulet.2009.01.021. Epub 2009 Jan 13. Neurosci Lett. 2009. PMID: 19152829
-
The blood-brain barrier in health and chronic neurodegenerative disorders.Neuron. 2008 Jan 24;57(2):178-201. doi: 10.1016/j.neuron.2008.01.003. Neuron. 2008. PMID: 18215617 Review.
-
Nitric oxide and neurological disorders.Mol Aspects Med. 2005 Feb-Apr;26(1-2):67-96. doi: 10.1016/j.mam.2004.09.004. Epub 2005 Jan 24. Mol Aspects Med. 2005. PMID: 15722115 Review.
-
[Does acidosis in brain play a role in Alzheimer's disease?].Neuropsychiatr. 2009;23(3):187-92. Neuropsychiatr. 2009. PMID: 19703385 German.
Cited by
-
Therapeutic Effects of Aβ-Specific Regulatory T Cells in Alzheimer's Disease: A Study in 5xFAD Mice.Int J Mol Sci. 2024 Jan 8;25(2):783. doi: 10.3390/ijms25020783. Int J Mol Sci. 2024. PMID: 38255856 Free PMC article.
-
Impaired glymphatic system revealed by DTI-ALPS in cerebral palsy due to periventricular leukomalacia: relation with brain lesion burden and hand dysfunction.Neuroradiology. 2024 Feb;66(2):261-269. doi: 10.1007/s00234-023-03269-9. Epub 2023 Dec 22. Neuroradiology. 2024. PMID: 38129651 Free PMC article.
-
Genetic topography and cortical cell loss in Huntington's disease link development and neurodegeneration.Brain. 2023 Nov 2;146(11):4532-4546. doi: 10.1093/brain/awad275. Brain. 2023. PMID: 37587097 Free PMC article.
-
The role of thrombin in early-onset seizures.Front Cell Neurosci. 2023 Mar 9;17:1101006. doi: 10.3389/fncel.2023.1101006. eCollection 2023. Front Cell Neurosci. 2023. PMID: 36970419 Free PMC article.
-
Chemokines in patients with Alzheimer's disease: A meta-analysis.Front Aging Neurosci. 2023 Mar 9;15:1047810. doi: 10.3389/fnagi.2023.1047810. eCollection 2023. Front Aging Neurosci. 2023. PMID: 36967827 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
